Bottom line
Is EGLBX a good fund? The bottom line
EGLBX is an actively managed international stock mutual fund from SPDR (State Street).
Annual fees run 0.37% — about $37 a year on every $10,000 invested, cheaper than 88% of international stock funds we track.
It returned +22.4% over one year, +6.9% a year over five years, +7.7% a year over ten (as of Dec 31, 2025, per its prospectus).
With $176 million in net assets and 60 holdings, its largest position is ASML Holding NV (4.9%) and the top 10 make up 29% of the portfolio.
What stands out
- Low cost: cheaper than 88% of international stock peers
- No front-end sales load
Updated Nov 19, 2026
What EGLBX invests in
Elfun International Equity Fund (the Fund) seeks long-term growth of capital and future income by investing principally in foreign securities consistent with prudent investment management and the preservation of capital.
The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets under normal circumstances in equity securities, such as common and preferred stocks. The Fund invests primarily (generally at least 65% of its net assets) in companies located in both developed and emerging market countries outside the U.S. The Fund considers an issuer to be located outside the U.S. if at least 50% of its revenues or profits are from business activities located outside the U.S., at least 50% of its assets are located outside the U.S. or the principal trading market for its securities is located outside the U.S. SSGA Funds Management, Inc. ( SSGA FM or the Adviser), the investment adviser to the Fund, focuses on companies whose security prices it believes do not fully reflect their potential for growth. An emerging market country is any country having an economy and market…
From the fund's prospectus (filed Apr 24, 2026).
EGLBX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| EGLBX | +22.4% | +6.9% | +7.7% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What EGLBX costs
On a $10,000 investment, EGLBX's 0.37% expense ratio costs about $37 a year. The prospectus estimates $468 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
EGLBX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 4.95% |
| 2 | Mitsubishi UFJ Financial Group Inc | 3.38% |
| 3 | ING Groep NV | 2.79% |
| 4 | Safran SA | 2.78% |
| 5 | Roche Holding AG | 2.69% |
| 6 | Schneider Electric SE | 2.59% |
| 7 | AstraZeneca PLC | 2.58% |
| 8 | Murata Manufacturing Co Ltd | 2.56% |
| 9 | Siemens Energy AG | 2.36% |
| 10 | Infineon Technologies AG | 2.28% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 29% of the fund. See all top 25 holdings and asset mix →